XAGE EBITDA

annual EBITDA:

-$10.50M+$4.69M(+30.87%)
December 1, 2024

Summary

  • As of today (June 19, 2025), XAGE annual EBITDA is -$10.50 million, with the most recent change of +$4.69 million (+30.87%) on December 1, 2024.
  • During the last 3 years, XAGE annual EBITDA has fallen by -$6.76 million (-180.96%).
  • XAGE annual EBITDA is now -180.96% below its all-time high of -$3.74 million, reached on December 1, 2021.

Performance

XAGE EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXAGEincome statement metrics

quarterly EBITDA:

-$1.43M-$461.70K(-47.82%)
March 1, 2025

Summary

  • As of today (June 19, 2025), XAGE quarterly EBITDA is -$1.43 million, with the most recent change of -$461.70 thousand (-47.82%) on March 1, 2025.
  • Over the past year, XAGE quarterly EBITDA has increased by +$2.04 million (+58.88%).
  • XAGE quarterly EBITDA is now -2147.63% below its all-time high of $69.70 thousand, reached on December 1, 2023.

Performance

XAGE quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXAGEincome statement metrics

TTM EBITDA:

-$8.46M+$2.04M(+19.46%)
March 1, 2025

Summary

  • As of today (June 19, 2025), XAGE TTM EBITDA is -$8.46 million, with the most recent change of +$2.04 million (+19.46%) on March 1, 2025.
  • Over the past year, XAGE TTM EBITDA has increased by +$8.62 million (+50.48%).
  • XAGE TTM EBITDA is now -2858.41% below its all-time high of -$285.90 thousand, reached on June 1, 2022.

Performance

XAGE TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherXAGEincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

XAGE EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+30.9%+58.9%+50.5%
3 y3 years-181.0%-399.2%-2858.4%
5 y5 years-181.0%-399.2%-2858.4%

XAGE EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-181.0%+30.9%-2147.6%+83.6%-2858.4%+52.8%
5 y5-year-181.0%+30.9%-2147.6%+83.6%-2858.4%+52.8%
alltimeall time-181.0%+30.9%-2147.6%+83.6%-2858.4%+52.8%

XAGE EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
-$1.43M(+47.8%)
-$8.46M(-19.5%)
Dec 2024
-$10.50M(-30.9%)
-$965.50K(-65.9%)
-$10.50M(+10.9%)
Sep 2024
-
-$2.83M(-12.6%)
-$9.47M(-38.3%)
Jun 2024
-
-$3.24M(-6.7%)
-$15.35M(-10.2%)
Mar 2024
-
-$3.47M(-5079.3%)
-$17.08M(+13.0%)
Dec 2023
-$15.19M
$69.70K(-100.8%)
-$15.11M(-15.6%)
DateAnnualQuarterlyTTM
Sep 2023
-
-$8.71M(+75.2%)
-$17.91M(+30.2%)
Jun 2023
-
-$4.97M(+230.2%)
-$13.76M(+51.6%)
Mar 2023
-
-$1.51M(-44.8%)
-$9.07M(+19.9%)
Dec 2022
-$5.06M(+35.4%)
-$2.73M(-40.1%)
-$7.57M(+56.4%)
Sep 2022
-
-$4.55M(+1491.9%)
-$4.84M(+1591.9%)
Jun 2022
-
-$285.90K
-$285.90K
Dec 2021
-$3.74M
-
-

FAQ

  • What is Longevity Health Holdings annual EBITDA?
  • What is the all time high annual EBITDA for Longevity Health Holdings?
  • What is Longevity Health Holdings annual EBITDA year-on-year change?
  • What is Longevity Health Holdings quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Longevity Health Holdings?
  • What is Longevity Health Holdings quarterly EBITDA year-on-year change?
  • What is Longevity Health Holdings TTM EBITDA?
  • What is the all time high TTM EBITDA for Longevity Health Holdings?
  • What is Longevity Health Holdings TTM EBITDA year-on-year change?

What is Longevity Health Holdings annual EBITDA?

The current annual EBITDA of XAGE is -$10.50M

What is the all time high annual EBITDA for Longevity Health Holdings?

Longevity Health Holdings all-time high annual EBITDA is -$3.74M

What is Longevity Health Holdings annual EBITDA year-on-year change?

Over the past year, XAGE annual EBITDA has changed by +$4.69M (+30.87%)

What is Longevity Health Holdings quarterly EBITDA?

The current quarterly EBITDA of XAGE is -$1.43M

What is the all time high quarterly EBITDA for Longevity Health Holdings?

Longevity Health Holdings all-time high quarterly EBITDA is $69.70K

What is Longevity Health Holdings quarterly EBITDA year-on-year change?

Over the past year, XAGE quarterly EBITDA has changed by +$2.04M (+58.88%)

What is Longevity Health Holdings TTM EBITDA?

The current TTM EBITDA of XAGE is -$8.46M

What is the all time high TTM EBITDA for Longevity Health Holdings?

Longevity Health Holdings all-time high TTM EBITDA is -$285.90K

What is Longevity Health Holdings TTM EBITDA year-on-year change?

Over the past year, XAGE TTM EBITDA has changed by +$8.62M (+50.48%)
On this page